OTCMINND
Market cap270mUSD
Jan 22, Last price
0.03USD
1D
-6.70%
1Q
-71.50%
IPO
-87.46%
Name
InnerScope Hearing Technologies, Inc.
Chart & Performance
P/E
—
P/S
73.11
EPS
—
Div Yield, %
—
Shrs. gr., 5y
136.33%
Rev. gr., 5y
62.62%
Revenues
4m
-75.83%
Net income
-11m
L
CFO
-4m
L-31.60%
Earnings
Apr 14, 2025
Profile
InnerScope Hearing Technologies, Inc. provides hearing aids and its hearable, and wearable personal sound amplifier products to retail hearing aid dispensing community. The company engages in the provision of manufacturing and direct-to-consumer distribution/retail of hearing aids, personal sound amplifier products, hearing related treatment therapies, doctor-formulated dietary hearing supplements, and proprietary CDB oil for treating tinnitus. It also owns and operates 11 audiological and retail hearing device clinics; and offers business to business SaaS based patient management system software program. The company was formerly known as Innerscope Advertising Agency, Inc. and changed its name to InnerScope Hearing Technologies, Inc. in August 2017. InnerScope Hearing Technologies, Inc. was incorporated in 2012 and is headquartered in Roseville, California.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | |
| Income | |||||||||
Revenues | 3,695 -75.83% | 15,284 -406,166.07% | |||||||
Cost of revenue | 509 | 9,644 | |||||||
Unusual Expense (Income) | |||||||||
NOPBT | 3,186 | 5,641 | |||||||
NOPBT Margin | 86.22% | 36.91% | |||||||
Operating Taxes | (10,975) | (2) | |||||||
Tax Rate | |||||||||
NOPAT | 14,161 | 5,641 | |||||||
Net income | (10,975) -296.83% | 5,576 16,125.02% | |||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | 5,886 | 350 | |||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | 491 | 546 | |||||||
Long-term debt | 1,157 | 2,597 | |||||||
Deferred revenue | |||||||||
Other long-term liabilities | 4,737 | 4,806 | |||||||
Net debt | 414 | 1,852 | |||||||
| Cash flow | |||||||||
Cash from operating activities | (3,627) | (5,303) | |||||||
CAPEX | (91) | (1,238) | |||||||
Cash from investing activities | (91) | (1,238) | |||||||
Cash from financing activities | 3,643 | 6,441 | |||||||
FCF | 20,330 | (4,673) | |||||||
| Balance | |||||||||
Cash | 2 | 77 | |||||||
Long term investments | 1,232 | 1,215 | |||||||
Excess cash | 1,050 | 527 | |||||||
Stockholders' equity | (23,437) | (12,787) | |||||||
Invested Capital | 44,283 | 39,791 | |||||||
ROIC | 33.69% | 16.61% | |||||||
ROCE | 15.28% | 20.89% | |||||||
| EV | |||||||||
Common stock shares outstanding | 5,815,996 | 6,923,149 | |||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | 3,440 | 6,101 | |||||||
EV/EBITDA | |||||||||
Interest | 2,814 | 3,008 | |||||||
Interest/NOPBT | 88.34% | 53.33% | |||||||